TY - JOUR
T1 - Screening for Peripheral Vascular Stiffness in Lipedema Patients by Automatic Electrocardiogram-Based Oscillometric Detection
AU - Mahlmann, Adrian
AU - Khorzom, Yazan
AU - Behrendt, Christian-Alexander
AU - Leip, Jennifer Lynne
AU - Bachler, Martin
AU - Wassertheurer, Siegfried
AU - Elzanaty, Nesma
AU - Ghazy, Tamer
N1 - © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https:// creativecommons.org/licenses/by/ 4.0/).
PY - 2024/3/5
Y1 - 2024/3/5
N2 - Body mass index (BMI) is seen as a predictor of cardiovascular disease (CVD) in lipedema patients. A valid predictor of CVD is increased aortic stiffness (IAS), and previous research described IAS in lipedema. However, it is not known if this applies to all patients. In this cross-sectional single-center cohort study, peripheral pulse wave velocity (PWV) as a non-invasive indicator of aortic stiffness was measured in 41 patients with lipedema, irrespective of stage and without pre-existing cardiovascular conditions or a history of smoking and a maximum body mass index (BMI) of 35 kg/m
2. Automatically electrocardiogram-triggered oscillometric sensor technology by the Gesenius-Keller method was used. Regardless of the stage of lipedema disease, there was no significant difference in PWV compared to published standard values adjusted to age and blood pressure. BMI alone is not a predictor of cardiovascular risk in lipedema patients. Measuring other anthropometric factors, such as the waist-hip ratio or waist-height ratio, should be included, and the existing cardiovascular risk factors, comorbidities, and adipose tissue distribution for accurate risk stratification should be taken into account. Automated sensor technology recording the PWV represents a valid and reliable method for health monitoring and early detection of cardiovascular risks.
AB - Body mass index (BMI) is seen as a predictor of cardiovascular disease (CVD) in lipedema patients. A valid predictor of CVD is increased aortic stiffness (IAS), and previous research described IAS in lipedema. However, it is not known if this applies to all patients. In this cross-sectional single-center cohort study, peripheral pulse wave velocity (PWV) as a non-invasive indicator of aortic stiffness was measured in 41 patients with lipedema, irrespective of stage and without pre-existing cardiovascular conditions or a history of smoking and a maximum body mass index (BMI) of 35 kg/m
2. Automatically electrocardiogram-triggered oscillometric sensor technology by the Gesenius-Keller method was used. Regardless of the stage of lipedema disease, there was no significant difference in PWV compared to published standard values adjusted to age and blood pressure. BMI alone is not a predictor of cardiovascular risk in lipedema patients. Measuring other anthropometric factors, such as the waist-hip ratio or waist-height ratio, should be included, and the existing cardiovascular risk factors, comorbidities, and adipose tissue distribution for accurate risk stratification should be taken into account. Automated sensor technology recording the PWV represents a valid and reliable method for health monitoring and early detection of cardiovascular risks.
KW - oscillometric measurement;
KW - peripheral vascular stiffness
KW - lipedema
KW - Humans
KW - Vascular Stiffness/physiology
KW - Pulse Wave Analysis
KW - Cohort Studies
KW - Cross-Sectional Studies
KW - Lipedema/complications
KW - Cardiovascular Diseases/diagnosis
KW - Electrocardiography
KW - Risk Factors
UR - https://www.mdpi.com/1424-8220/24/5/1673/s1?version=1709621910
U2 - 10.3390/s24051673
DO - 10.3390/s24051673
M3 - Article
C2 - 38475209
SN - 1424-3210
VL - 24
SP - 1
EP - 11
JO - Sensors
JF - Sensors
IS - 5
M1 - 1673
ER -